Singular Genomics Systems, Inc.
DelistedCIK 1850906fmd_1AT7GYMQNCDFJKA0JS3FBCZF01Manufacturing · Laboratory Analytical InstrumentsTemplate: Standard
Coverage: Jan 01, 2020 to Sep 30, 2024, 19 periods
Latest annual · FY2023
Millions- Total revenues
- 3
- Gross profit
- (1)
- Operating income
- (103)
- Net income
- (95)
- Free cash flow
- (75)
Latest quarter · Q3 FY2024
Millions- Total revenues
- 0
- Gross profit
- (0)
- Operating income
- (18)
- Net income
- (17)
- Free cash flow
- (20)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2020 to FY2023
- n/m
Singular Genomics Systems, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2023 | FY2022 | Change | Source |
|---|---|---|---|---|
| Revenue | $2.9 million | $765,000 | +280.5% | 10-K 2024-03-18 · proof |
| Gross profit | -$558,000 | -$24,000 | 10-K 2024-03-18 · proof | |
| Operating income | -$102.8 million | -$93.5 million | 10-K 2024-03-18 · proof | |
| Net income | -$94.8 million | -$90.9 million | 10-K 2024-03-18 · proof | |
| Cash from operating activities | -$73.6 million | -$87.1 million | 10-K 2024-03-18 · proof | |
| Free cash flow | -$74.6 million | -$93.1 million | 10-K 2024-03-18 · proof | |
| Total assets | $265.5 million | $328 million | -19.1% | 10-K 2024-03-18 · proof |
| Total liabilities | $86.5 million | $67.7 million | +27.8% | 10-K 2024-03-18 · proof |
| Cash and cash equivalents | $16.2 million | $74.3 million | -78.1% | 10-K 2024-03-18 · proof |
| Total debt | $10.2 million | $10.1 million | +1.5% | 10-K 2024-03-18 · proof |
- What was Singular Genomics Systems, Inc.'s revenue in fiscal 2023?
- Singular Genomics Systems, Inc. reported revenue of $2.9 million for fiscal 2023 (the year ended Dec 31, 2023), against $765,000 the year before (+280.5%). Source: the 10-K filed with the SEC on Mar 18, 2024. SEC
- What was Singular Genomics Systems, Inc.'s gross profit in fiscal 2023?
- Singular Genomics Systems, Inc. reported gross profit of -$558,000 for fiscal 2023 (the year ended Dec 31, 2023), against -$24,000 the year before. Source: the 10-K filed with the SEC on Mar 18, 2024. SEC
- What was Singular Genomics Systems, Inc.'s operating income in fiscal 2023?
- Singular Genomics Systems, Inc. reported operating income of -$102.8 million for fiscal 2023 (the year ended Dec 31, 2023), against -$93.5 million the year before. Source: the 10-K filed with the SEC on Mar 18, 2024. SEC
- What was Singular Genomics Systems, Inc.'s net income in fiscal 2023?
- Singular Genomics Systems, Inc. reported net income of -$94.8 million for fiscal 2023 (the year ended Dec 31, 2023), against -$90.9 million the year before. Source: the 10-K filed with the SEC on Mar 18, 2024. SEC
- What was Singular Genomics Systems, Inc.'s cash from operating activities in fiscal 2023?
- Singular Genomics Systems, Inc. reported cash from operating activities of -$73.6 million for fiscal 2023 (the year ended Dec 31, 2023), against -$87.1 million the year before. Source: the 10-K filed with the SEC on Mar 18, 2024. SEC
- What was Singular Genomics Systems, Inc.'s free cash flow in fiscal 2023?
- Singular Genomics Systems, Inc. reported free cash flow of -$74.6 million for fiscal 2023 (the year ended Dec 31, 2023), against -$93.1 million the year before. Source: the 10-K filed with the SEC on Mar 18, 2024. SEC
- What are Singular Genomics Systems, Inc.'s total assets?
- As of Dec 31, 2023, Singular Genomics Systems, Inc. reported total assets of $265.5 million, against $328 million a year earlier (-19.1%). Source: the 10-K filed with the SEC on Mar 18, 2024. SEC
- What are Singular Genomics Systems, Inc.'s total liabilities?
- As of Dec 31, 2023, Singular Genomics Systems, Inc. reported total liabilities of $86.5 million, against $67.7 million a year earlier (+27.8%). Source: the 10-K filed with the SEC on Mar 18, 2024. SEC
- What are Singular Genomics Systems, Inc.'s cash and cash equivalents?
- As of Dec 31, 2023, Singular Genomics Systems, Inc. reported cash and cash equivalents of $16.2 million, against $74.3 million a year earlier (-78.1%). Source: the 10-K filed with the SEC on Mar 18, 2024. SEC
- What is Singular Genomics Systems, Inc.'s total debt?
- As of Dec 31, 2023, Singular Genomics Systems, Inc. reported total debt of $10.2 million, against $10.1 million a year earlier (+1.5%). Source: the 10-K filed with the SEC on Mar 18, 2024. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1850906&period_type=annual&limit=5"Information only, not investment advice.